A clinical study on Swasakasam (Bronchial Asthma) with the evaluation of siddha drug Sombu Theeneer

The clinical study on Swasakasam was carried out on Post graduate department of Maruthuvam, Government Siddha Medical College, Arignar Anna Hospital, Chennai-106 during the period of 2015 -2017. A total of 40 patients were treated in the Outpatient department. The clinical and pathological assessment was carried out on the basis of Siddha and Modern aspects. All patients were treated with SOMBU THEENEER (15ml bid with equal amount of warm water) for duration of 30 days. The peak incidence of Swasakasam was found to be in 31-40 years of age group of both sexes. The prevalence of the disease was high among Lower class populations 57.5% followed by Middle class 22.5% and High class population 20%. Out of 40 patients, 9 patient (22.5%) was tailor, 14 patient (35%) were office people, 5patient (12.5%) was traffic policeman, 3 patients (7.5%) were business man, 6 patients (15%) were housewife, 3 patient (7.5%) were student. Regarding personal habits 11 patients were smokers, 4 patients were alcoholic, 3 patients were both smoking and alcoholic, 1 patient was a snuff user. Remaining 21 patients were tee tootlers. Among the dietary patterns, 82.5% consume mixed diet and 17.5% are purely vegetarian. Out of 40 patients, 37.5% comes under Vatha kaalam, 62.5% comes under Azhal kaalam. From selected 40 patients,16 patients(40%) comes under Kaarkaalam, 9 patients (22.5%) comes under Koothirkaalam,7 patients(17.5%) comes under Munpani, 5 patients (12.5%) comes under Pinpani, 2 patients(5%) comes under Elavenil, 1patient (2.5%) comes under Mudhuvenil. Out of 40 patients, 33 patients (82.5%) comes under Neidhal, 7 patients (17.5%) comes under Marudham. From the selected 40 patients, Pranan was affected in 40 patients (100%), Abanan was affected in 5 patients (12.5%), Viyanan was affected in 35 patients (87.5%), Samanan was affected in 14 patients (35%), Koorman was affected in3 patients (7.5%), Kirugaran was affected in 30 patients (75%), Devathan was affected in 40 patients (100%). Out of 40 patients, Analagam was affected in1 4 patients (35%), Ranjagam was affected in 9 patients (22.5%), Saathagam was affected in 40 patients (100%), Aalosagam was affected in 3 patients (7.5%). Out of 40 patients, Avalambagam was affected in 40 patients (100%), Klethagam was affected in 14 patients (35%), Santhigam was affected in 5 patients (12.5%). Out of 40 cases, Saaram was affected in 40 patients (100%), Seneer was affected in 9 patients (22.5%), Enbu was affected in 5 patients(12.5%). Regarding Envagaithervu, Naa was affected in 9 patients (22.5%), Mozhi was affected in 1 patients(2.5%), Vizhi was affected in 9 patients (22.5%), Malam was affected in 5 patients (12.5%), Naadi was affected in 40 patients (100%). Out of 40 patients, 31 patients had Kabhavatha naadi and 9 patients had Vathakabh anaadi. Out of 40 patients, 9 patients (22.5%) had Vatha neer, 31 patients (77.5%) had Kabhaneer. Regarding peak expiratory flow rate (75%) got good results and 10 patients (25%) got moderate results. The ingredient Sombu has the property kaarpu suvai of neutralizing the deranged iyya kutram. The toxicity studies revealed no toxicity in Sombu Theeneer. The pharmacological activity of Sombu Theeneer shows Bronchodilator activity. The Biostatsistical report of the clinical trial significant p value P